These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 1472536)

  • 1. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
    Angles-Cano E; Rouy D; Lijnen HR
    Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
    Rouy D; Anglés-Cano E
    Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu.
    Rouy D; Grailhe P; Nigon F; Chapman J; Anglés-Cano E
    Arterioscler Thromb; 1991; 11(3):629-38. PubMed ID: 1827591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism.
    Angles-Cano E; Gris JC; Loyau S; Schved JF
    J Lab Clin Med; 1993 May; 121(5):646-53. PubMed ID: 8478593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein.
    Silverstein RL; Leung LL; Harpel PC; Nachman RL
    J Clin Invest; 1985 Jun; 75(6):2065-73. PubMed ID: 4008652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
    Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
    J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histidine-rich glycoprotein and alpha 2-plasmin inhibitor in inhibition of plasminogen binding to fibrin.
    Ichinose A; Mimuro J; Koide T; Aoki N
    Thromb Res; 1984 Feb; 33(4):401-7. PubMed ID: 6710439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation by alpha 2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma.
    Silence K; Collen D; Lijnen HR
    Blood; 1993 Aug; 82(4):1175-83. PubMed ID: 7688990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein (a) regulates plasmin generation and inhibition.
    Edelberg J; Pizzo SV
    Chem Phys Lipids; 1994 Jan; 67-68():363-8. PubMed ID: 8187236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a synthetic carboxy-terminal peptide of alpha(2)-antiplasmin on urokinase-induced fibrinolysis.
    Lee KN; Jackson KW; McKee PA
    Thromb Res; 2002 Feb; 105(3):263-70. PubMed ID: 11927133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody directed against the high-affinity lysine-binding site (LBS) of human plasminogen. Role of LBS in the regulation of fibrinolysis.
    Holvoet P; Lijnen HR; Collen D
    Eur J Biochem; 1986 May; 157(1):65-9. PubMed ID: 2940088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.
    Sakata Y; Aoki N
    J Clin Invest; 1982 Mar; 69(3):536-42. PubMed ID: 7199538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncovalent interaction of alpha(2)-antiplasmin with fibrin(ogen): localization of alpha(2)-antiplasmin-binding sites.
    Tsurupa G; Yakovlev S; McKee P; Medved L
    Biochemistry; 2010 Sep; 49(35):7643-51. PubMed ID: 20687529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clot lysis induced by a monoclonal antibody against alpha 2-plasmin inhibitor.
    Sakata Y; Eguchi Y; Mimuro J; Matsuda M; Sumi Y
    Blood; 1989 Dec; 74(8):2692-7. PubMed ID: 2510836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
    Thorsen S; Müllertz S; Suenson E; Kok P
    Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of the process of Glu-plasminogen activation by tissue activator with fibrin, DDE-complex, and D-dimer using alpha-2-antiplasmin].
    Hrynenko TV; Zadorozhna MB; Platonova TM; Volkov HL
    Ukr Biokhim Zh (1999); 2005; 77(5):45-51. PubMed ID: 16846069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis.
    Schneider M; Nesheim M
    J Biol Chem; 2004 Apr; 279(14):13333-9. PubMed ID: 14715655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview on fibrinolysis: plasminogen activation pathways on fibrin and cell surfaces.
    Anglés-Cano E
    Chem Phys Lipids; 1994 Jan; 67-68():353-62. PubMed ID: 8187235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice.
    Okada K; Ueshima S; Tanaka M; Fukao H; Matsuo O
    Blood Coagul Fibrinolysis; 2000 Oct; 11(7):645-55. PubMed ID: 11085285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.